Fig. 3From: The impact of blood transcriptomic biomarker targeted tuberculosis preventive therapy in people living with HIV: a mathematical modelling studyResults by relative efficacy of preventive therapy in RISK11-positive individuals. Solid lines show median model output; shaded regions show 95% range of model outputs. Colours indicate different time horizons (see key). Left panel: ratio of cases averted (compared to universal treatment). Right panel: maximum cost of test (relative to 3HP) such that cost per case averted does not exceed cost per case averted of universal treatmentBack to article page